Grannus

Developer of small molecule inhibitors for the treatment of oncology

placeIndianapolis, Indiana, United States calendar_todayFounded 2019 groups2 employees language grannustherapeutics.com

Social engagement

Social engagement: 287 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

21 Oct 2025
Product launch
Coming soon